Correlation Between IShares Healthcare and ARK Genomic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Healthcare and ARK Genomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Healthcare and ARK Genomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Healthcare Providers and ARK Genomic Revolution, you can compare the effects of market volatilities on IShares Healthcare and ARK Genomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Healthcare with a short position of ARK Genomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Healthcare and ARK Genomic.

Diversification Opportunities for IShares Healthcare and ARK Genomic

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between IShares and ARK is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding iShares Healthcare Providers and ARK Genomic Revolution in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ARK Genomic Revolution and IShares Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Healthcare Providers are associated (or correlated) with ARK Genomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ARK Genomic Revolution has no effect on the direction of IShares Healthcare i.e., IShares Healthcare and ARK Genomic go up and down completely randomly.

Pair Corralation between IShares Healthcare and ARK Genomic

Considering the 90-day investment horizon iShares Healthcare Providers is expected to under-perform the ARK Genomic. But the etf apears to be less risky and, when comparing its historical volatility, iShares Healthcare Providers is 2.26 times less risky than ARK Genomic. The etf trades about -0.09 of its potential returns per unit of risk. The ARK Genomic Revolution is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  2,639  in ARK Genomic Revolution on August 30, 2024 and sell it today you would lose (96.00) from holding ARK Genomic Revolution or give up 3.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.44%
ValuesDaily Returns

iShares Healthcare Providers  vs.  ARK Genomic Revolution

 Performance 
       Timeline  
iShares Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Healthcare Providers has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Etf's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the Exchange Traded Fund stockholders.
ARK Genomic Revolution 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ARK Genomic Revolution has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward-looking signals, ARK Genomic is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

IShares Healthcare and ARK Genomic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Healthcare and ARK Genomic

The main advantage of trading using opposite IShares Healthcare and ARK Genomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Healthcare position performs unexpectedly, ARK Genomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARK Genomic will offset losses from the drop in ARK Genomic's long position.
The idea behind iShares Healthcare Providers and ARK Genomic Revolution pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance